Limbach Holdings (LMB) Tops Q3 EPS by 23c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus
Go back to Limbach Holdings (LMB) Tops Q3 EPS by 23c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 79.09 -2.28 (2.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.37 | 52 Week High | $0.15 | |||
| Open | $82.59 | 52 Week Low | $0.15 | |||
| Day High | $84.36 | P/E | N/A | |||
| Day Low | $78.62 | EPS | $0.00 | |||
| Volume | 352,220 | |||||
